Research group working at the interface of molecular epidemiology, computational biology and clinical medicine. Focus on inflammation, #lupus & #vasculitis

Imperial College London
Joined May 2021
In 2025 we reported ­­⬆️ plasma tenascin-C (TNC) in large-vessel #vasculitis : (both GCA & Takayasu arteritis) : doi.org/10.1002/art.43110 Now in @JCI_insight Shi et al doi.org/10.1172/jci.insight.… show TNC is not just a marker of vascular injury but contributes to inflammation
3
26
Peters Lab retweeted
Sunday Spotlight💫: Presenting the most comprehensive proteomic map of systemic #Lupus erythematosus to date (>6000 proteins)! doi.org/10.1172/jci.insight.… Geoffrey H. D. Leung @gleung23 James E. Peters @lab_peters & team @imperialcollege report potential therapeutic targets, biomarkers, and autoantibody-linked proteomic signatures in #SLE, providing a basis for precision medicine. The figure shows SLE disease activity–associated proteins correlated with IFNL1. @MedResFdn
10
35
3,324
🔬 Final version live in @JCIInsight: Most comprehensive plasma #proteomic profiling in #lupus to date: >6,500 proteins, ~350 participants. Discovery of autoantibody-defined proteomic endotypes provides a basis for precision medicine 📄insight.jci.org/articles/vie…
1
1
62
Huge thanks to the study team, the patients & healthy volunteers who made this possible 🙏, and to @MedResFdn & @ImperialBRC for funding this work. Also a shout-out to the editorial team & Ken Beauchamp @JCIInsight for a superbly professional review and production process
23
Delighted that our study mapping the #proteome in #SLE is now published in @JCI_insight . Great work from the team especially grad student Geoffrey Leung insight.jci.org/articles/vie…
1
2
1
4
1,001
-dsDNA autoantibody positivity is associated with ⬆️soluble CD40 ligand and ⬆️plasma proteinase-3 -In dsDNA +ve SLE: there's a positive association between sCD40L and disease activity -In the dsDNA -ve group: NO association
1
17
CONCLUSION: this is a basis for precision medicine. Pharma should trial anti-CD40L pathway therapy in the dsDNA+ SLE population. Testing in all SLE risks trial failure due to dilution of signal
16
Geoffrey Leung, PhD student from our lab, presenting his exciting work on #proteomic profiling in #lupus at #HumanImmune26. Preprint here: medrxiv.org/content/10.1101/… Hopefully peer reviewed publication to follow soon...
2
42
Excellent perspective article on field of immunology. Why single cell atlases alone are not sufficient and the dangers of subspecialisation. We need to borrow some of the physics mindset rdcu.be/e3OtP
28
Delighted to be speaking at the Kennedy Institute of Rheumatology, Oxford @KirOxford outlining our research using #proteomics in immune-mediated diseases (#IMD) and proteogenomic studies in population-scale cohorts for insights into IMD aetiology talks.ox.ac.uk/talks/id/ef1d…
25
Our multi-omic study on COVID19 in ESKD now published in @CellGenomics. Single-cell transcriptome, surface proteome and immunoreceptor sequencing of longitudinal samples, including paired pre-infection and acute infection samples sciencedirect.com/science/ar…
39
Plasma @OlinkProteomics study of large vessel vasculitis spectrum revealed •Highly similar proteomic signatures in Takayasu & GCA •↑ Innate immune activation, and ↑ stromal remodeling Results have implications for biomarker and drug design In A&R doi.org/10.1002/art.43110
1
14
37
2,647